Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000259

EVP, Corp and Development Ops sold 23,900 shares at an average $72.13 ($1,723,987)

  • EVP, Corp and Development Ops acquired 23,900 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Birchler Brian · EVP, Corp and Development Ops

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-14 Exercise or conversion : show line 1 in the form 10b5-1 +11,475 $53.77 $617,011 68,301 D
2025-10-14 Sale : show line 2 in the form 10b5-1 −11,475 $72.03 $826,589 56,826 D
2025-10-15 Exercise or conversion : show line 3 in the form 10b5-1 +12,425 $53.77 $668,092 69,251 D
2025-10-15 Sale : show line 4 in the form 10b5-1 −12,425 $72.23 $897,398 56,826 D
Open-market sales · 23,900 sh · avg $72.13 · $1,723,987

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-10-14 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −11,475 12,425 D
2025-10-15 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −12,425 0 D
Loading xslF345X05/edgardoc.xml…